Ambaw Bellete
Präsident bei CG ONCOLOGY, INC.
Vermögen: - $ am 30.04.2024
Profil
Ambaw Bellete currently works at OncoSTING LLC, as Chairman, Axiom REACH Foundation, as Director, and CG Oncology, Inc., as President & Chief Operating Officer from 2023.
Mr. Bellete also formerly worked at Lion Healthcare Strategies LLC, as Chief Executive Officer from 2021 to 2023, Photocure ASA, as Head-US Cancer Commercial Operations, BioNJ, Inc., as Trustee, Photocure, Inc., as President from 2012 to 2019, and FerGene, Inc., as Chief Operating Officer from 2020 to 2021.
Mr. Bellete received his undergraduate degree from Murray State University (Kentucky).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CG ONCOLOGY, INC.
-.--% | 25.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Ambaw Bellete
| Unternehmen | Position | Beginn |
|---|---|---|
| CG ONCOLOGY, INC. | Präsident | 01.07.2023 |
| OncoSTING LLC | Vorsitzender | - |
Ehemalige bekannte Positionen von Ambaw Bellete
| Unternehmen | Position | Ende |
|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Geschäftsführer | 01.03.2021 |
| Photocure, Inc. | Präsident | 01.08.2019 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | - |
| PHOTOCURE ASA | Corporate Officer/Principal | - |
Ausbildung von Ambaw Bellete
| Murray State University (Kentucky) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
| Photocure, Inc. | |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
| OncoSTING LLC |
